Gland Pharma Ltd

NSE: GLAND · BSE: 543245 · Pharmaceuticals & Biotechnology · 47 announcements

Gland Pharma Ltd news stories on ALFA NewsRead the news →

Share price: ₹3,159.00
Market cap: ₹52,127 Cr
Revenue (annual): ₹6,431 Cr
Net profit (annual): ₹1,027 Cr
P/E (TTM): 46.2×Sector 47.4×
Promoter holding: 51.77%-0.06% QoQ
FII holding: 8.74%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

5 Aug 2026 16:03 IST NSE

Gland Pharma Capacity Expansion

Gland Pharma announced a long-term strategic CDMO partnership with Neuland Laboratories to expand its sterile API manufacturing infrastructure at its Visakhapatnam facility.

Read the filing ↗